Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Herantis Pharma

1.76 EUR

-3.08 %

4,556 following
Corporate customer

HRTIS

First North Finland

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Investor consensus
Valuation
Income statement
Quarterly estimates

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Herantis Pharma

P/E (adj.)

Median 2021-2025

EV/EBIT (adj.)

Median 2021-2025

Dividend yield

Median 2021-2025

P/B

Median 2021-2025

 
20192020202120222023202420252026e2027e2028e2029e
Share price (EUR)7.374.152.401.651.581.522.041.761.761.761.76
Shares9.811.116.920.220.224.134.834.834.834.8
Market cap40.526.627.931.930.649.261.461.461.461.4
Enterprise value34.426.426.525.428.546.651.759.167.882.3
EV/S-8,593.46,606.46,613.76,360.32,854.04,658.35,167.45,911.36,782.58,234.4
EV/EBITDA-neg.neg.neg.165.2neg.neg.neg.neg.neg.neg.
EV/EBIT (adj.)-neg.neg.neg.165.2neg.neg.neg.neg.neg.neg.
EV/EBIT-neg.neg.neg.165.2neg.neg.neg.neg.neg.neg.
P/E (adj.)-neg.neg.neg.114.2neg.neg.neg.neg.neg.neg.
P/E-neg.neg.neg.114.2neg.neg.neg.neg.neg.neg.
P/B-5.3neg.neg.6.8neg.neg.6.224.4neg.neg.
P/S-10,122.96,662.46,976.27,963.63,064.54,915.46,138.36,138.36,138.36,138.3
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio46.2 %-14.7 %-1.1 %69.9 %-11.4 %-63.3 %100.0 %100.0 %-2,474.6 %-8,277.4 %
Gearing ratio-80.6 %19.6 %2,071.4 %-136.0 %718.4 %152.1 %-97.5 %-90.1 %-104.0 %-101.2 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.